Skip to main content
Man Group PLC logo

Man Group PLC — Investor Relations & Filings

Ticker · M3N ISIN · JE00BJ1DLW90 LEI · 2549003YWC1DW6LALB09 IL Financial and insurance activities
Open in API
Filings indexed 5,207 across all filing types
Latest filing 2021-08-06 Major Shareholding Noti…
Country JE Jersey
Listing IL M3N

About Man Group PLC

https://www.man.com/

Man Group PLC is an active investment management firm focused on delivering performance and client portfolio solutions. The company provides a range of alternative and long-only investment strategies across public and private markets for a global client base of institutional and high-net-worth investors. A key aspect of its approach is the integration of cutting-edge technology, quantitative expertise, and a data-driven culture to identify investment opportunities. The firm continuously invests in talent, technology, and research to manage capital for its clients, which include millions of savers.

Recent filings

Filing Released Lang Actions
Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
Major Shareholding Notification Classification · 95% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013'. This form is used for 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' during a takeover situation. This type of filing relates to insider transactions or significant stake changes during a takeover bid, which aligns closely with Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), but the specific context of a takeover disclosure points towards filings related to M&A activity or insider transactions during such events. Since the filing details transactions by 'Man Group PLC' in 'STRONGBRIDGE BIOPHARMA PLC' during a period where takeover rules are invoked, it is a specific type of insider/major shareholder disclosure related to a potential takeover. Among the provided codes, 'TAR' (M&A Activity) is the most relevant context, as these disclosures are mandatory during takeover bids. However, the content is strictly about 'Dealings' by a person with an interest, which is the core function of 'DIRS' (Director's Dealing) or 'MRQ' (Major Shareholding Notification). Given the context of a takeover (TAR), and the nature of reporting personal/firm dealings (DIRS/MRQ), 'TAR' captures the overarching event driving the disclosure. If a more specific 'Takeover Disclosure' code existed, it would be used. Since this is a mandatory disclosure of dealings during a takeover process, 'TAR' (M&A Activity) is the best fit to categorize the regulatory context, although 'DIRS' is also plausible for the transaction type itself. I will select TAR as the primary driver for this specific form type (Form 8.3).
2021-08-06 English
Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
Director's Dealing Classification · 98% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL' rules, detailing 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This form is used to disclose personal share transactions (dealings) by directors or major shareholders during a takeover period. This aligns directly with the definition of Director's Dealing (DIRS) or, more broadly, insider trading disclosures related to corporate actions. Since the document details specific purchases and sales by 'Man Group PLC/Jersey' concerning 'STRONGBRIDGE BIOPHARMA PLC' shares, it is a report of insider/major shareholder transactions. Among the provided codes, 'DIRS' (Director's Dealing) is the closest fit for reporting personal share transactions by executives/insiders, even though this specific form (Form 8.3) is related to takeover rules, which often trigger such disclosures. Given the options, DIRS captures the essence of reporting personal security dealings by an interested party.
2021-08-05 English
Man Group PLC : Form 8.3 - Bally's Corporation
Major Shareholding Notification Classification · 97% confidence The document explicitly states it is a "FORM 8.3" which is a "PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" under Rule 8.3 of the Takeover Code. This type of filing relates to insider dealings or significant position changes during a takeover scenario. Reviewing the provided definitions, the closest match for reporting personal share transactions by executives/insiders, especially in the context of M&A activity (which is implied by the Takeover Code reference), is 'Director's Dealing' (DIRS). While this is specifically a Takeover Code disclosure (Rule 8.3), it fundamentally reports on the interests and dealings of a person connected to an offer, which aligns best with the scope of DIRS, as opposed to general M&A activity (TAR) or general regulatory filings (RNS). Given the specific nature of reporting insider/significant shareholder dealings related to a takeover, DIRS is the most appropriate classification among the choices.
2021-08-05 English
Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
Major Shareholding Notification Classification · 96% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL' rules, detailing 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This form is used to disclose personal share transactions by directors or significant shareholders during a takeover period. This aligns directly with the definition of Director's Dealing (insider trades) or, more broadly, a filing related to insider transactions during a corporate action. Since the filing concerns personal share transactions by an entity (Man Group PLC) in another company (STRONGBRIDGE BIOPHARMA PLC) during a potential takeover scenario, the most fitting category among the provided options is 'Director's Dealing' (DIRS), which covers executive/insider transactions. Although it's a takeover-related filing, 'M&A Activity' (TAR) is for the proposal/bid itself, whereas this is a mandatory disclosure of resulting insider trades. 'DIRS' is the closest match for mandatory disclosure of personal security dealings by insiders/major holders.
2021-08-04 English
Man Group PLC : Form 8.3 - Bally's Corporation
Major Shareholding Notification Classification · 96% confidence The document explicitly states it is a "FORM 8.3" which is a "PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" under Rule 8.3 of the Takeover Code. This form details insider/significant shareholder dealings and positions related to a takeover offer (Bally's Corporation and Gamesys Group plc). This type of filing, concerning director/insider transactions during a takeover context, most closely aligns with the 'Director's Dealing' category (DIRS), although it is a specific regulatory disclosure related to takeovers. Since DIRS covers personal share transactions by directors/executives, and this form details significant dealings by Man Group PLC in relation to an offer, it fits the spirit of insider/significant transaction reporting. However, given the specific context of takeover rules (Rule 8.3), it is a specialized form of insider disclosure. Reviewing the provided codes, 'DIRS' (Director's Dealing) is the closest fit for reporting personal share transactions by executives/insiders, even if this specific form is mandated by the Takeover Code.
2021-08-04 English
Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
Director's Dealing Classification · 98% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL' rules, concerning 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This form details transactions (purchases/sales) and resulting interests in securities by a party involved in a takeover situation (Man Group PLC dealing in STRONGBRIDGE BIOPHARMA PLC). This type of filing, which reports insider/significant shareholder transactions related to a specific corporate action like a takeover, is best categorized under Director's Dealing (DIRS) as it reports personal/insider share transactions, or potentially Regulatory Filings (RNS) if DIRS is too narrow. However, given the specific nature of reporting personal dealings/interests during a takeover, and comparing it against the provided definitions, it most closely aligns with the spirit of reporting insider transactions, which is covered by DIRS. Since DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this is an insider/major shareholder dealing disclosure, DIRS is the most appropriate specific code. If DIRS were not available, RNS would be the fallback. Since DIRS is available, I select DIRS.
2021-08-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.